Healthtech firm Biofourmis earns unicorn tag with $300m Series D round

Kuldeep Singh Rajput, Founder and CEO at Biofourmis

Singapore-founded digital therapeutics firm Biofourmis announced raising $300 million in a Series D funding round led by growth equity firm General Atlantic, taking its valuation past the $1 billion mark.

The announcement confirmed DealStreetAsia’s report earlier this month that said the company, which focuses on delivering virtual care and developing novel digital therapies, was set to become a unicorn in a round that will be led by General Atlantic.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter